Paul Peter Tak - Dec 8, 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Executive Officer, Director
Signature
/s/ Jason A. Amello, as Attorney-in-Fact for Paul Peter Tak
Stock symbol
CADL
Transactions as of
Dec 8, 2022
Transactions value $
$30,020
Form type
4
Date filed
12/12/2022, 03:25 PM
Previous filing
Nov 30, 2022
Next filing
May 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Purchase $5.19K +3.05K +12.2% $1.70 28.1K Dec 8, 2022 Direct F1
transaction CADL Common Stock Purchase $24.8K +12.9K +46.11% $1.92 41K Dec 9, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.89 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.